Biotech Growth Trust plc (The) (BIOG) Ordinary 25p
12.00p
(0.92%)
- Add to watchlist
- Create an alert
- This stock can be held in a
12.00p
(0.92%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
12.00p
(0.92%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
1,320.00p
1,330.00p
1,750.00p
1,302.20
1,306.00p
1,306.04p
1,060.00p
0.29%
36.00p (2.83%) Previous:
36.00p
94,467
n/a
GBX
Price
-
Net Asset Value (NAV)
Performance
| 1 week 1W | 3.62% | 1 year 1Y | 16.43% |
|---|---|---|---|
| 1 month 1M | 8.85% | 2 years 2Y | 85.63% |
| 3 months 3M | 20.89% | 3 years 3Y | 81.54% |
| 6 months 6M | 9.48% | 5 years 5Y | 123.01% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Trust Basics
| Benchmark: | NASDAQ Biotechnology TR GBP |
|---|---|
| Annual management charge: | 0.65% of Net Assets |
| Performance fee: | Yes |
| Ongoing charge: | 1.10% |
| Dividend yield: | n/a |
| Dividend frequency: | Annually |
| Total assets: | £563m |
| Gross gearing: | 103% |
| Market capitalisation:Market cap.: | £544m |
| Shares in issue: | 41.66 million |
| Legal structure | Closed Ended Investment Company |
| Domicile: | United Kingdom |
| ISIN | GB0000385517 |
Dividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
To buy shares in , you'll need to have an account.
Try our handy filter to explore the different options.
Ready to invest?
To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.
Important Documents
Objective
NET ASSET VALUE (NAV)
| Estimated NAV: | 1,302.20 |
|---|---|
| Latest actual NAV: | 1,454.37 |
| Latest actual NAV date: | 1 April 2021 |
| Premium/Discount: | 0.29% |
| 12m average Premium/Discount: | -0.63% |
| NAV frequency: | Daily |
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
| Security | Weight |
|---|---|
| Neurocrine Biosciences Inc | 4.18% |
| Vertex Pharmaceuticals Inc | 4.01% |
| Turning Point Therapeutics Inc | 3.88% |
| Horizon Therapeutics plc Ordinary Shares | 3.83% |
| Alexion Pharmaceuticals Inc | 2.91% |
| Curis Inc | 2.74% |
| Biogen Inc | 2.60% |
| Keros Therapeutics Inc | 2.60% |
| Prelude Therapeutics Inc Ordinary Shares | 2.50% |
| Amgen Inc | 2.48% |
| Sector | Weight |
|---|---|
| Healthcare | 99.88% |
| Country | Weight |
|---|---|
| United States | 72.66% |
| China | 12.49% |
| Canada | 8.44% |
| Switzerland | 2.22% |
| United Kingdom | 2.14% |
| Cayman Islands | 1.05% |
| France | 0.93% |
| Denmark | 0.40% |
| Ireland | 0.33% |
| Germany | 0.28% |
Key Dates
| Launch date: | 23 June 1997 |
|---|---|
| Financial year end: | March |
| Next AGM: | July 2021 |
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.